Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma

NCT05937438 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

70

Enrollment

OTHER_GOV

Sponsor class

Conditions

Esophageal Carcinoma

Interventions

DRUG: Immune Checkpoint Inhibitors

Sponsor

Anhui Provincial Hospital